Skip to main content
. 2022 Apr 26;12(5):1085. doi: 10.3390/diagnostics12051085

Table 1.

Characteristics of included patients. Abbreviations: SD, standard deviation; HBV, hepatitis B; HCV, hepatitis C; NAFLD, non-alcoholic fatty liver disease; BCP, birth control pills; RF, risk factors; PH, portal hypertension; Y, yes; N, no; G1, well-differentiated HCC; G2, moderately differentiated HCC; G3, poorly differentiated HCC; NA, not assessed; AJCC, American Joint Committee on Cancer.

Clinical Characteristic Value
Age (mean ± SD) 57.8 ± 15.3
Sex (n (%))
  Male 26 (68.4)
  Female 12 (31.6)
Risk factors (n (%))
  HBV 3 (7.9)
  HBV|tobacco 2 (5.3)
  HCV 5 (13.2)
  HCV|tobacco 2 (5.3)
  HCV|alcohol 1 (2.63)
  Alcohol 9 (23.7)
  Tobacco 1 (2.6)
  Tobacco|BCP 1 (2.6)
  NAFLD 2 (5.3)
  Hemochromatosis 1 (2.6)
  No history of RF 10 (26.3)
  NA 1 (2.6)
PH 1 (n (%))
  Y 9 (23.7)
  N 29 (76.3)
Histologic grade (n (%))
  G1 7 (18.4)
  G2 15 (39.5)
  G3 16 (42.1)
AJCC stage 2 (n (%))
I 15 (39.5)
II 12 (31.6)
III 10 (26.3)
IV 1 (2.6)

1 A portal vein diameter greater than 13 mm was assumed to be the cutoff point for PH [44,45,46]. 2 The AJCC staging system (ranging from the 5th through the 7th edition) was applied to classify the pathologic staging [47,48,49].